ProfileGDS4814 / ILMN_1678949
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 78% 76% 76% 80% 76% 77% 76% 78% 77% 74% 78% 76% 80% 77% 77% 80% 78% 80% 78% 79% 77% 79% 77% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)120.93878
GSM780708Untreated after 4 days (C2_1)104.19576
GSM780709Untreated after 4 days (C3_1)109.03176
GSM780719Untreated after 4 days (C1_2)150.56780
GSM780720Untreated after 4 days (C2_2)107.01176
GSM780721Untreated after 4 days (C3_2)116.17677
GSM780710Trastuzumab treated after 4 days (T1_1)108.18376
GSM780711Trastuzumab treated after 4 days (T2_1)123.93778
GSM780712Trastuzumab treated after 4 days (T3_1)113.64977
GSM780722Trastuzumab treated after 4 days (T1_2)92.070174
GSM780723Trastuzumab treated after 4 days (T2_2)119.2578
GSM780724Trastuzumab treated after 4 days (T3_2)103.49676
GSM780713Pertuzumab treated after 4 days (P1_1)144.27680
GSM780714Pertuzumab treated after 4 days (P2_1)115.92377
GSM780715Pertuzumab treated after 4 days (P3_1)114.99477
GSM780725Pertuzumab treated after 4 days (P1_2)144.38980
GSM780726Pertuzumab treated after 4 days (P2_2)122.34278
GSM780727Pertuzumab treated after 4 days (P3_2)139.73480
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)121.92978
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)135.55879
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)111.43277
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)130.36979
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)117.89377